ArticleDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapyPublished
Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- Published
- Topic
- Disease research
- Subject terms
- Humans; Deoxycytidine Kinase; Nucleotides; BRCA2 Protein; Antineoplastic Agents; Protein Kinase Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Parp Inhibitors Brca2 Nucleotides Metabolism Synthetic Lethality Targeted Therapies
- PubMed ID
- 36706533
- Added to directory
- Source checked